Plain-English translation of NCT07242573 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two new approaches to help people with fibromyalgia manage their symptoms: personalized exercise training on special equipment, and a non-invasive treatment called transcutaneous neuromodulation (NESA X-Signal) that uses gentle electrical signals to reduce pain. Both approaches are combined with standard physical therapy. The study will compare how well these treatments work compared to conventional therapy alone over a 6-week period.
Fibromyalgia causes widespread pain, exhaustion, and sleep problems that are difficult to treat with standard care alone. This trial is exploring whether adding either targeted exercise or nerve stimulation might help patients feel significantly better and improve their quality of life.
You likely qualify if…
You likely don't qualify if…
If you are randomly selected into one of the treatment groups, you will attend supervised sessions 5 times per week for 3 weeks. You'll either do personalized exercise training using specialized equipment, receive 30-minute nerve stimulation treatments, or continue with standard physical therapy. All participants will have their pain, sleep quality, fatigue, mood, and mobility measured at the start and end of the program using questionnaires and movement assessments.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Poland